Biotech continues to make good progress in 2025 with key regulatory and clinical advancements, reinforcing pelareorep’s ...

GHO has a deep understanding of the CDMO sector and Avid perfectly exemplifies a company that is operating in high growth markets supporting the growing biotech sector in research ... targeting ...

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

Metsera is a clinical-stage biotechnology company developing injectable and oral treatments for obesity and related conditions, the filing shows. The company’s investors include affiliates of ...

Share prices for some of the biggest American tech brands that crested the AI hype waves crashed this morning on the rocks of DeepSeek, a Chinese startup that last week released LLMs that challenges ...

The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin condition known as chronic spontaneous urticaria, or chronic hives.

Sara Choi, biotech investor and partner at the Palo Alto, California-based Wing Venture Capital is very optimistic. “I think there’s going to be three times the number of approved drugs in the next ...

Pfizer acquired Biohaven for $11.6bn in October 2022 based on a strong sales forecast for Nurtec ODT. Image credit: Shutterstock/Molly Woodward. Pfizer has agreed to pay $59.7m to resolve illegal ...

Washington — Vice President JD Vance said Saturday that "we believe fundamentally that big tech does have too much power," despite the prominent positioning of tech CEOs at President Trump's ...

Unfortunately, all his dreams were shattered when he was shot to death in New Haven, Connecticut, by Qinxuan Pan, an MIT graduate. Consisting of exclusive interviews with the victim’s loved ones and ...

Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences. © 2025 Fortune Media IP Limited ...

The buzz around biotech IPOs is continuing through January ... Aardvark’s pipeline is headed up by ARD-101, a bitter taste receptor (TAS2R) pan-agonist designed to stimulate enteroendocrine ...